Impaired structural correlates of memory in Alzheimer's disease mice
Open accessThe DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
The healthy adult brain demonstrates robust learning-induced neuroanatomical plasticity. While altered neuroanatomical plasticity is suspected to be a factor mitigating the progressive cognitive decline in Alzheimer's disease (AD), it is not known to what extent this plasticity is affected by AD. We evaluated whether spatial learning and memory-induced neuroanatomical plasticity are diminished in an adult mouse model of AD (APP mice) featuring amyloid beta-driven cognitive and cerebrovascular dysfunction. We also evaluated the effect of early, long-term pioglitazone-treatment on functional hyperemia, spatial learning and memory, and associated neuroanatomical plasticity. Using high-resolution post-mortem MRI and deformation-based morphometry, we demonstrate spatial learning and memory-induced focal volume increase in the hippocampus of wild-type mice, an effect that was severely attenuated in APP mice, consistent with their unsuccessful performance in the spatial Morris water maze. These findings implicate impaired neuroanatomical plasticity as an important contributing factor to cognitive deficits in the APP mouse model of AD. Pioglitazone-treatment in APP mice completely rescued functional hyperemia and exerted beneficial effects on spatial learning and memory-recall, but it did not improve hippocampal plasticity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Navigation-related structural change in the hippocampi of taxi drivers
Maguire, E. A., Gadian, D. G., Johnsrude, I. S., Good, C. D., Ashburner, J., Frackowiak, R. S. J., & Frith, C. D. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.070039597 · Cited by 3,225
Changes in grey matter induced by training
Draganski, B., Gaser, C., Busch, V., Schuierer, G., Bogdahn, U., & May, A. (2004) · Nature · doi:10.1038/427311a · Cited by 2,373 · cited 4×
“Using high-resolution post-mortem MRI and deformation-based morphometry, we demonstrate spatial learning and memory-induced focal volume increase in the hippocampus of wild-type mice, an effect that was severely attenuated in APP mice, consistent with their unsuccessful performance in the spatial Morris water maze.”
BackgroundInfluentialNeurovascular regulation in the normal brain and in Alzheimer's disease
Iadecola, C. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1387 · Cited by 2,213
Mucke, L., Masliah, E., Yu, G.-Q., Mallory, M., Rockenstein, E. M., Tatsuno, G., Hu, K., Kholodenko, D., Johnson-Wood, K., & McConlogue, L. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-11-04050.2000 · Cited by 1,856 · cited 3×
“The APP/J20 line carries one copy of the familial early-onset AD Swedish (670/671KM → NL) and Indiana (717V → F) APP mutations on the C57BL/6J background (Mucke et al., 2000).”
BackgroundMethodInfluentialEffects of Aβ immunization (AN1792) on MRI measures of cerebral volume in Alzheimer disease
Fox, N. C., Black, R. S., Gilman, S., Rossor, M. N., Griffith, S. G., Jenkins, L., & Koller, M. (2005) · Neurology · doi:10.1212/01.wnl.0000159743.08996.99 · Cited by 550 · cited 1×
“gliosis and edema) in the absence of brain tissue loss (Fox et al., 2005; Maheswaran et al., 2009); (b) hAPP overexpression-induced increase in neurogenesis (Jin et al.”
BackgroundEfficacy of PPAR-γ agonist pioglitazone in mild Alzheimer disease
Sato, T., Hanyu, H., Hirao, K., Kanetaka, H., Sakurai, H., & Iwamoto, T. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.10.009 · Cited by 387
Vascular risk factors promote conversion from mild cognitive impairment to Alzheimer disease
Li, J., Wang, Y. J., Zhang, M., Xu, Z. Q., Gao, C. Y., Fang, C. Q., Yan, J. C., & Zhou, H. D. (2011) · Neurology · doi:10.1212/wnl.0b013e318217e7a4 · Cited by 367
Villain, N., Desgranges, B., Viader, F., de la Sayette, V., Mezenge, F., Landeau, B., Baron, J.-C., Eustache, F., & Chetelat, G. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.1392-08.2008 · Cited by 366 · cited 1×
“Volumetric reductions in CG (Villain et al., 2008) and CC (Di Paola et al.”
BackgroundMaze training in mice induces MRI-detectable brain shape changes specific to the type of learning
Lerch, J. P., Yiu, A. P., Martinez-Canabal, A., Pekar, T., Bohbot, V. D., Frankland, P. W., Henkelman, R. M., Josselyn, S. A., & Sled, J. G. (2011) · NeuroImage · doi:10.1016/j.neuroimage.2010.09.086 · Cited by 300 · cited 7×
“All rights reser morphometry (DBM), we showed specific growth in the dorsal hippocampus (equivalent to posterior hippocampus in human) of mice trained for five days on the spatial Morris water maze (MWM) (Lerch et al., 2011a).”
BackgroundMethodInfluentialSelf-citationNicolakakis, N., Aboulkassim, T., Ongali, B., Lecrux, C., Fernandes, P., Rosa-Neto, P., Tong, X.-K., & Hamel, E. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.3348-08.2008 · Cited by 262
Mapping local hippocampal changes in Alzheimer's disease and normal ageing with MRI at 3 Tesla
Frisoni, G. B., Ganzola, R., Canu, E., Rub, U., Pizzini, F. B., Alessandrini, F., Zoccatelli, G., Beltramello, A., Caltagirone, C., & Thompson, P. M. (2008) · Brain · doi:10.1093/brain/awn280 · Cited by 256 · cited 1×
“Our finding in APP mice is consistent with the MRI-detectable sub-regional CA1 volume decreases apparent in early AD (Frisoni et al., 2008; Kerchner et al., 2010).”
ResultTreatment of vascular risk factors is associated with slower decline in Alzheimer disease
Deschaintre, Y., Richard, F., Leys, D., & Pasquier, F. (2009) · Neurology · doi:10.1212/wnl.0b013e3181b59bf3 · Cited by 232 · cited 1×
“Since treatment of vascular risk factors and/or vascular co-morbidities has been shown to slow cognitive decline (Deschaintre et al., 2009; Li et al., 2011), pioglitazone may be of benefit to AD patients with concurrent cerebrovascular deficits.”
BackgroundGeldmacher, D. S., Fritsch, T., McClendon, M. J., & Landreth, G. (2011) · Archives of Neurology · doi:10.1001/archneurol.2010.229 · Cited by 221 · cited 3×
“, 2009), and has been recommended for testing in earlier disease stages of AD (Geldmacher et al., 2011).”
BackgroundNiwa, K., Kazama, K., Younkin, S. G., Carlson, G. A., & Iadecola, C. (2002) · Neurobiology of Disease · doi:10.1006/nbdi.2001.0460 · Cited by 218 · cited 1×
“Together, the results confirm that cerebrovascular insufficiency, in particular reduced baseline (Hebert et al., 2013; Niwa et al., 2002) and stimulus-evoked CBF (Niwa et al.”
ResultIacono (2009) · doi:10.1212/wnl.0b013e3181b01077 · Cited by 203
Aggleton, J., Neave, N., Nagle, S., & Sahgal, A. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-11-07270.1995 · Cited by 196 · cited 1×
“In rodents, CG and CC lesions impair spatial behaviour (Aggleton et al., 1995), including spatial MWM performance (Warburton et al.”
BackgroundHippocampal CA1 apical neuropil atrophy in mild Alzheimer disease visualized with 7-T MRI
Kerchner, G. A., Hess, C. P., Hammond-Rosenbluth, K. E., Xu, D., Rabinovici, G. D., Kelley, D. A. C., Vigneron, D. B., Nelson, S. J., & Miller, B. L. (2010) · Neurology · doi:10.1212/wnl.0b013e3181f736a1 · Cited by 193 · cited 1×
“Our finding in APP mice is consistent with the MRI-detectable sub-regional CA1 volume decreases apparent in early AD (Frisoni et al., 2008; Kerchner et al., 2010).”
ResultNeuropathologic Studies of the Baltimore Longitudinal Study of Aging (BLSA)
O'Brien, R. J., Resnick, S. M., Zonderman, A. B., Ferrucci, L., Crain, B. J., Pletnikova, O., Rudow, G., Iacono, D., Riudavets, M. A., Driscoll, I., et al. (2009) · Journal of Alzheimer's Disease · doi:10.3233/jad-2009-1179 · Cited by 137
Asymptomatic Alzheimers Disease: A Prodrome or a State of Resilience?
Driscoll, I., & Troncoso, J. (2011) · Current Alzheimer Research · doi:10.2174/156720511795745348 · Cited by 130
Copenhaver, B. R., Rabin, L. A., Saykin, A. J., Roth, R. M., Wishart, H. A., Flashman, L. A., Santulli, R. B., McHugh, T. L., & Mamourian, A. C. (2006) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2006.01.015 · Cited by 112 · cited 1×
“Volumedecreases in the latter two structures has also been reported in AD patients (Andersen et al., 2012; Copenhaver et al., 2006; Wegiel et al., 1999).”
BackgroundResistance to Alzheimer's pathology is associated with nuclear hypertrophy in neurons
Riudavets, M. A., Iacono, D., Resnick, S. M., O’Brien, R., Zonderman, A. B., Martin, L. J., Rudow, G., Pletnikova, O., & Troncoso, J. C. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.05.005 · Cited by 106 · cited 1×
“While the latter requires investigation inmurineADmodels, cortical and hippocampal neuronal hypertrophy has been demonstrated in asymptomatic AD cohorts from the Baltimore Longitudinal Study of Aging (O'Brien et al., 2009; Riudavets et al., 2007) and the Nun Study (Iacono et al.”
Wanted dead or alive? The tradeoff between in-vivo versus ex-vivo MR brain imaging in the mouse
Lerch, J. P., Gazdzinski, L., Germann, J., Sled, J. G., Henkelman, R. M., & Nieman, B. J. (2012) · Frontiers in Neuroinformatics · doi:10.3389/fninf.2012.00006 · Cited by 104 · cited 2×
“In order to maximize our power to detect learning-related volume changes in these mice, we acquired high quality images post mortem with a resolution and contrast not obtainable in vivo (Lerch et al., 2012).”
BackgroundSelf-citationNeurovascular Pathways and Alzheimer Amyloid β-peptide
Zlokovic, B. V., Deane, R., Sallstrom, J., Chow, N., & Miano, J. M. (2006) · Brain Pathology · doi:10.1111/j.1750-3639.2005.tb00103.x · Cited by 104
Davies, D. C., Horwood, N., Isaacs, S. L., & Mann, D. M. A. (1992) · Acta Neuropathologica · doi:10.1007/bf00310028 · Cited by 88 · cited 1×
“Neuron loss in the CA1, in particular the CA1sp, has been documented in AD patients (Davies et al., 1992).”
BackgroundAmyloid precursor protein increases cortical neuron size in transgenic mice
Oh, E. S., Savonenko, A. V., King, J. F., Fangmark Tucker, S. M., Rudow, G. L., Xu, G., Borchelt, D. R., & Troncoso, J. C. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.12.024 · Cited by 75 · cited 1×
“, 2004), and/or a shift in the distribution of neuronal cell size toward larger neurons (Oh et al., 2009); and (c) compensatory neuronal hypertrophy, an early cellular attempt at offsetting neuronal injury induced byAβ (Driscoll and Troncoso, 2011).”
BackgroundUsing genetics to enable studies on the prevention of Alzheimer's disease
Crenshaw, D. G., Gottschalk, W. K., Lutz, M. W., Grossman, I., Saunders, A. M., Burke, J. R., Welsh-Bohmer, K. A., Brannan, S. K., Burns, D. K., & Roses, A. D. (2013) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2012.222 · Cited by 70 · cited 1×
“A clinical trial testing the ability of a low dose of pioglitazone to delay the onset of MCI of the AD type is expected to launch this year (Crenshaw et al., 2013).”
BackgroundApolipoprotein E ε4-related thickening of the cerebral cortex modulates selective attention
Espeseth, T., Westlye, L. T., Walhovd, K. B., Fjell, A. M., Endestad, T., Rootwelt, H., & Reinvang, I. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.12.027 · Cited by 32
Cited by
Bassoon contributes to tau-seed propagation and neurotoxicity
Martinez, P., Patel, H., You, Y., Jury, N., Perkins, A., Lee-Gosselin, A., Taylor, X., You, Y., Viana Di Prisco, G., Huang, X., et al. (2022) · Nature Neuroscience · doi:10.1038/s41593-022-01191-6 · Cited by 68
Holmes, H. E., Powell, N. M., Ma, D., Ismail, O., Harrison, I. F., Wells, J. A., Colgan, N., O'Callaghan, J. M., Johnson, R. A., Murray, T. K., et al. (2017) · Frontiers in Neuroinformatics · doi:10.3389/fninf.2017.00020 · Cited by 55
Grandjean, J., Derungs, R., Kulic, L., Welt, T., Henkelman, M., Nitsch, R. M., & Rudin, M. (2016) · NeuroImage · doi:10.1016/j.neuroimage.2016.03.042 · Cited by 48
Kong, V., Devenyi, G. A., Gallino, D., Ayranci, G., Germann, J., Rollins, C., & Chakravarty, M. M. (2018) · Brain Structure and Function · doi:10.1007/s00429-018-1691-4 · Cited by 32
Detcheverry, F. E., Senthil, S., Motue, W. L. K., Hosein, C., Arnaoutelis, R., Araujo, D., Fetco, D., Assemlal, H.-E., Antel, S., Arnold, D. L., et al. (2024) · doi:10.1101/2024.09.24.24313962 · Cited by 9
Self-citation
Metadata
- Authors
- Badhwar, A., Lerch, J. P., Hamel, E., & Sled, J. G.
- Venue
- NeuroImage: Clinical
- Publisher
- Elsevier BV
- Published
- 2013
- Volume
- 3
- Pages
- 290-300
- ISSN
- 2213-1582 (ISSN-L)
- OpenAlex
- W1976391664
- Cited by
- 45
- References
- 27
- FWCI
- 1.84
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.